TA
HZNP

Teachers Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Teachers Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$34.9M Buy
1,320,387
+103,325
+8% +$2.45M 0.04% 427
2018
Q4 		$23.8M Buy
1,217,062
+8,704
+0.7% +$171K 0.03% 522
2018
Q3 		$23.7M Buy
1,208,358
+16,484
+1% +$313K 0.03% 638
2018
Q2 		$19.7M Sell
1,191,874
-5,815
-0.5% -$88.7K 0.02% 743
2018
Q1 		$17M Buy
1,197,689
+35,266
+3% +$521K 0.02% 785
2017
Q4 		$17M Buy
1,162,423
+92,743
+9% +$1.3M 0.02% 812
2017
Q3 		$13.6M Buy
1,069,680
+775,120
+263% +$9.86M 0.02% 894
2017
Q2 		$3.5M Buy
294,560
+11,672
+4% +$145K ﹤0.01% 1506
2017
Q1 		$4.18M Sell
282,888
-609,823
-68% -$9.88M 0.01% 1387
2016
Q4 		$14.4M Buy
892,711
+28,363
+3% +$514K 0.02% 784
2016
Q3 		$15.7M Buy
864,348
+606,842
+236% +$11.9M 0.03% 715
2016
Q2 		$4.24M Buy
+257,506
New +$4.17M 0.01% 1244
2015
Q4 		– Sell
-216,100
Closed -$4.28M – 3113
2015
Q3 		$4.28M Sell
216,100
-46,100
-18% -$1.46M 0.01% 1175
2015
Q2 		$9.11M Buy
262,200
+168,825
+181% +$5.15M 0.02% 939
2015
Q1 		$2.42M Buy
93,375
+2,051
+2% +$37.6K ﹤0.01% 1529
2014
Q4 		$1.18M Buy
91,324
+337
+0.4% +$4.22K ﹤0.01% 1942
2014
Q3 		$1.12M Hold
90,987
– – ﹤0.01% 1959
2014
Q2 		$1.44M Buy
90,987
+9,665
+12% +$138K ﹤0.01% 1847
2014
Q1 		$1.23M Hold
81,322
– – ﹤0.01% 1888
2013
Q4 		$620K Buy
81,322
+10,137
+14% +$54.7K ﹤0.01% 2268
2013
Q3 		$241K Buy
71,185
+9,929
+16% +$26.2K ﹤0.01% 2723
2013
Q2 		$151K Buy
+61,256
New +$147K ﹤0.01% 2906

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Teachers Advisors's HZNP Position: Q1 2019 in Review

Teachers Advisors increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 8.5% in Q1 2019, buying an estimated $2.45M and bringing the position to 1,320,387 shares worth $34.9M. The position accounts for 0.04% of the portfolio, ranked #427.

Teachers Advisors first reported a position in HZNP in Q2 2013 and has held it in 22 quarters since. 297 funds tracked by Wall St. Rank hold HZNP as of Q1 2019.

  • Teachers Advisors held 1,320,387 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $34.9M as of Q1 2019.
  • Teachers Advisors bought 103,325 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2019, an estimated $2.45M.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.04% of Teachers Advisors's portfolio in Q1 2019, its #427 holding.
  • Teachers Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and has held it in 22 quarters since.
  • 297 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.